Peripheral Blood Neoantigen Specific T Cells Predict the Efficacy of Immunotherapy for Esophageal Squamous Cell Carcinoma
Clinical trial NCT05633641 · UNKNOWN
Trial details
- NCT number
- NCT05633641
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-10-19
- Primary completion
- 2023-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.